Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance by Qingli Cui, Yanhui Hu, Qingan Cui, Daoyuan Wu, Yuefeng Mao, Dongyang Ma, Huaimin Liu

Get full text

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer by Qingli Cui, Yuefeng Mao, Daoyuan Wu, Yanhui Hu, Dongyang Ma, LiHan Zhang, Huaimin Liu

Get full text

Nanodrugs systems for therapy and diagnosis of esophageal cancer by Lihan Zhang, Xing Li, Guangxing Yue, Lihao Guo, Yanhui Hu, Qingli Cui, Jia Wang, Jingwen Tang, Huaimin Liu

Get full text